Arkolith/Insider Trading/ELYM/Form 4

Morisset Valerie

EVP, R&D AND CSOEliem Therapeutics, Inc. (ELYM) · full profile →Form 4 · filed Jul 23, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$988K
Net Open-Market Flow
-$988K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 22, 2024Sell(S)39K$8.07$315K61K
Jul 22, 2024Sell(S)30K$7.98$239K31K
Jul 19, 2024Sell(S)50K$7.24$362K100K
Jul 19, 2024Sell(S)10K$7.09$72K150K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-019946) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML